Skip to content
This project is a randomised controlled clinical trial by the George Institute for Global Health. It will investigate if a polypill (single pill containing fixed-dose combination of treatments) will improve the adherence and health outcomes of patients with cardiovascular disease, as opposed to those using standard interventions.
The research will involve 1,000 Indigenous patients at risk of a cardiovascular event determined by a formal assessment process. It will be conducted in Aboriginal Community Controlled Health Services and general medical practices in Australia. Participants in the study will be monitored for approximately 18 months.
Abstract adapted from the George Institute for Global Health
Professor Anushka Patel
The George Institute for Global Health
321 Kent Street
Sydney NSW 2000
Ph: (02) 8238 2439
Ph: (02) 9657 0300
Fax: (02) 9657 0301